![Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy | Scientific Reports Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-02572-w/MediaObjects/41598_2021_2572_Fig1_HTML.png)
Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy | Scientific Reports
![Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients | Scientific Reports Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep40136/MediaObjects/41598_2017_Article_BFsrep40136_Fig3_HTML.jpg)
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients | Scientific Reports
![Frontiers | A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening Frontiers | A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening](https://www.frontiersin.org/files/Articles/623199/fimmu-11-623199-HTML-r1/image_m/fimmu-11-623199-g001.jpg)
Frontiers | A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening
![Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients | Scientific Reports Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep40136/MediaObjects/41598_2017_Article_BFsrep40136_Fig1_HTML.jpg)
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients | Scientific Reports
![Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID - ScienceDirect Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S232905012100022X-fx1.jpg)
Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID - ScienceDirect
![Frontiers | Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease Frontiers | Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease](https://www.frontiersin.org/files/Articles/608653/fimmu-11-608653-HTML/image_m/fimmu-11-608653-g001.jpg)